We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUN icon
2251
Sunrun
RUN
$2.42B
$167K ﹤0.01%
12,122
-516
-4% -$7.69K
VPV icon
2252
Invesco Pennsylvania Value Municipal Income Trust
VPV
$201M
$166K ﹤0.01%
12,616
+800
+7% +$10.6K
SSP icon
2253
E.W. Scripps
SSP
$307M
$163K ﹤0.01%
10,387
GSIT icon
2254
GSI Technology
GSIT
$253M
$162K ﹤0.01%
22,897
+75
+0.3% +$567
FMO
2255
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$161K ﹤0.01%
4,087
-516
-11% -$20.1K
ASUR icon
2256
Asure Software
ASUR
$243M
$160K ﹤0.01%
19,500
-1,000
-5% -$8.34K
JCE icon
2257
Nuveen Core Equity Alpha Fund
JCE
$290M
$160K ﹤0.01%
+10,968
New +$158K
FIV
2258
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$159K ﹤0.01%
+17,300
New +$156K
PCG icon
2259
PG&E
PCG
$38.1B
$157K ﹤0.01%
14,469
+1,896
+15% +$16.2K
BVN icon
2260
Compañía de Minas Buenaventura
BVN
$8.84B
$154K ﹤0.01%
10,204
-172
-2% -$2.55K
REZI icon
2261
Resideo Technologies
REZI
$3.67B
$154K ﹤0.01%
12,871
-1,155
-8% -$13.1K
S
2262
DELISTED
Sprint Corporation
S
$151K ﹤0.01%
29,068
+1,424
+5% +$8.35K
MYN icon
2263
BlackRock MuniYield New York Quality Fund
MYN
$376M
$150K ﹤0.01%
11,434
+29
+0.3% +$376
OIA icon
2264
Invesco Municipal Income Opportunities Trust
OIA
$290M
$150K ﹤0.01%
19,036
-5,882
-24% -$45.9K
NERV icon
2265
Minerva Neurosciences
NERV
$206M
$149K ﹤0.01%
2,625
FT
2266
Franklin Universal Trust
FT
$198M
$147K ﹤0.01%
18,841
+411
+2% +$3.14K
IGA
2267
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
$147K ﹤0.01%
13,993
-2,425
-15% -$25.2K
JDD
2268
DELISTED
Nuveen Diversified Dividend and Income Fund
JDD
$147K ﹤0.01%
13,539
+2,056
+18% +$22.4K
PFX icon
2269
PhenixFIN
PFX
$88.9M
$146K ﹤0.01%
3,347
-336
-9% -$14.8K
MYI icon
2270
BlackRock MuniYield Quality Fund III
MYI
$717M
$145K ﹤0.01%
10,709
+487
+5% +$6.56K
DHF
2271
BNY Mellon High Yield Strategies Fund
DHF
$175M
$144K ﹤0.01%
46,391
+247
+0.5% +$754
NRO
2272
Neuberger Real Estate Securities Income Fund Inc
NRO
$187M
$141K ﹤0.01%
26,410
-4,853
-16% -$26K
JCO
2273
DELISTED
Nuveen Credit Opportunities 2022 Target Term Fund
JCO
$141K ﹤0.01%
14,045
+45
+0.3% +$444
PTE
2274
DELISTED
PolarityTE, Inc. Common Stock
PTE
$140K ﹤0.01%
2,147
+334
+18% +$24.1K
FOF icon
2275
Cohen & Steers Closed End Opportunity Fund
FOF
$380M
$136K ﹤0.01%
10,150
-981
-9% -$12.9K

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.